Oxford study to trial cannabis-based medicine as treatment for psychosis

CBD is currently only prescribed for a small number of conditions such as rare, severe epilepsy

Oxford scientists are to launch a major global trial to investigate whether cannabis-based medicine can treat people with psychosis or psychotic symptoms.

Currently, cannabidiol (CBD) is only prescribed for a small number of conditions. In the UK, for example, these include rare, severe epilepsy, and vomiting or nausea caused by chemotherapy.